Skip to main content

Table 2 Comparison of adverse maternal complications

From: Proteinuria may be an indicator of adverse pregnancy outcomes in patients with preeclampsia: a retrospective study

 

Non-PE

PE

p value

Subgroupsb

p value

A

B

C

Numbera

54

275

 

53

64

53

 

Mode of delivery

 Spontaneously (%)

38 (70.4)

24 (8.7)

<  0.001

6 (11.3)

1 (1.7)

1 (5.7)

0.038

 Caesarean section (%)

14 (25.9)

232 (84.4)

 

46 (86.8)

59 (92.2)

42 (79.2)

 

 Adverse maternal outcomes (%)

2 (3.7)

92 (33.5)

<  0.001

11 (21)

21 (32.8)

26 (49.1)

0.009

 Retinal disease (%)

0

19 (6.9)

0.047

1 (1.9)

2 (3.1)

3 (5.7)

0.561

 Hypoproteinemia (%)

1 (1.9)

44 (16)

0.006

3 (5.7)

8 (12.5)

19 (35.8)

< 0.001

 Organ dysfunctionc (%)

0

20 (7.3)

0.041

3 (5.7)

0

7 (13.2)

0.010

 Placental abruption (%)

0

10 (3.6)

0.155

1 (1.9)

3 (4.7)

1 (1.9)

0.578

 Oligohydramnios (%)

0

29 (10.6)

0.012

6 (11.3)

8 (12.5)

3(11.3)

0.437

 Effusiond (%)

0

2 (0.7)

0.53

0

0

1 (1.9)

0.329

 Eclampsia (%)

0

1 (0.4)

0.657

0

0

0

 Postpartum hemorrhage (%)

2 (3.7)

3 (1)

0.151

0

1 (1.7)

0

0.435

 DIC (%)

0

2 (0.7)

0.53

0

0

0

 Hemorrhagic anemia (%)

1 (1.9)

6 (2.2)

0.878

0

0

1 (1.9)

0.329

 Maternal death (%)

0

1 (0.4)

0.657

0

0

0

  1. Numbera: The number of multiple adverse pregnancy outcomes was counted according to the types of adverse pregnancy outcomes
  2. Subgroupsb: A: 24-h urinary protein < 0.3 g; B:24-h urinary protein 0.3 ~ 2 g; C:24-h urinary protein 2 g
  3. Organ dysfunctionc: renal dysfunction, hepatic dysfunction or cardiac insufficiency
  4. Effusiond: including pleural or peritoneal effusion or pericardial effusion